<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01037660</url>
  </required_header>
  <id_info>
    <org_study_id>H-23660</org_study_id>
    <nct_id>NCT01037660</nct_id>
  </id_info>
  <brief_title>Effects of Lipemia and Metformin on Endothelial Function</brief_title>
  <official_title>Effects of Lipemia and Metformin on Endothelial Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Eating a diet high in fat contributes to the development of atherosclerosis (hardening of the
      arteries). Acute fat consumption increases levels of fat in the blood and temporarily reduces
      the ability of blood vessel to dilate (open up to carry additional blood). A similar response
      is observed during infusion of Intra-Lipid (a fat emulsion used for intravenous nutrition).
      The present study is designed to help us understand the effects of a fat load on blood vessel
      function. We will measure arterial dilation using non-invasive techniques before and at the
      end of a 5-hour infusion of Intra-Lipid in healthy subjects. Subjects will then take the
      approved drug metformin for two weeks and return for repeat studies of endothelial function
      with Intra-Lipid infusion. We expect that metformin will help preserve the normal function of
      blood vessels during a fat load. This study will help us understand how fat affects blood
      vessels and therefore will advance our knowledge of the development of atherosclerosis and
      potentially lead to improved methods to prevent and treat heart disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2005</start_date>
  <completion_date type="Actual">December 1, 2016</completion_date>
  <primary_completion_date type="Actual">December 1, 2015</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Brachial artery flow-mediated dilation</measure>
    <time_frame>6 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood lipid levels</measure>
    <time_frame>6 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">139</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Metformin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metformin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>Metformin 1 gram per day</description>
    <arm_group_label>Metformin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

        Exclusion Criteria:

          -  Pregnancy (defined as positive urine pregnancy test)

          -  Diabetes Mellitus (Clinical history or random blood glucose&gt;140 mg/dl)

          -  Hypertension (Clinical history or SBP&gt;140 or DBP&gt;90 mmHg)

          -  History of adverse reaction to metformin

          -  Abnormal renal function (Serum creatinine&gt;1.4 mg/dl)

          -  Abnormal liver function (AST or ALT greater than two times the upper limit of normal)

          -  Administration of iodinated contrast within 7 days

          -  History of congestive heart failure

          -  Abnormal clotting parameters (INR&gt;1.5 or PTT&gt;40 sec)

          -  Anemia (HCT&lt;30%)

          -  Allergy to soy or egg

          -  Allergy to heparin

          -  The potential subject plans to perform heavy exercise in the setting of low calorie
             intake during the period of the study such as running or competitive road or bicycle
             racing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naomi Hamburg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2009</study_first_submitted>
  <study_first_submitted_qc>December 21, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2009</study_first_posted>
  <last_update_submitted>March 8, 2017</last_update_submitted>
  <last_update_submitted_qc>March 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston University</investigator_affiliation>
    <investigator_full_name>Naomi M Hamburg</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>endothelium</keyword>
  <keyword>cardiovascular disease</keyword>
  <keyword>dietary fat</keyword>
  <keyword>insulin resistance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

